Edition:
India

Cardinal Health Inc (CAH.N)

CAH.N on New York Stock Exchange

45.79USD
30 Oct 2020
Change (% chg)

$0.18 (+0.39%)
Prev Close
$45.61
Open
$45.49
Day's High
$46.26
Day's Low
$45.15
Volume
2,667,401
Avg. Vol
658,821
52-wk High
$60.69
52-wk Low
$39.24

Summary

Name Age Since Current Position

Gregory Kenny

67 2018 Non-Executive Chairman of the Board

Michael Kaufmann

57 2019 Chief Executive Officer, Director

Jason Hollar

46 2020 Chief Financial Officer

Victor Crawford

58 2018 Chief Executive Officer - Pharmaceutical segment

Stephen Mason

48 2019 Chief Executive Officer-Medical Segment

Ola Snow

52 2018 Chief Human Resource Officer

Brian Rice

56 2019 Executive Vice President, Chief Information Officer and Customer Support Services

Jessica Mayer

50 2019 Chief Legal and Compliance Officer

Carrie Cox

62 2009 Independent Director

Calvin Darden

69 2005 Independent Director

Bruce Downey

72 2009 Independent Director

Sheri Edison

63 2020 Independent Director

David Evans

56 2020 Independent Director

Patricia Hemingway Hall

67 2013 Independent Director

Akhil Johri

58 2018 Independent Director

Nancy Killefer

66 2015 Independent Director

John Losh

73 2018 Independent Director

Dean Scarborough

63 2019 Independent Director

John Weiland

63 2019 Independent Director

Biographies

Name Description

Gregory Kenny

Mr. Gregory B. Kenny is re designated as Non-Executive Chairman of the Board of the company effective November 2018. Mr. Kenny served as President and Chief Executive Officer of General Cable Corporation, a global manufacturer of aluminum, copper and fiber-optic wire and cable products, from 2001 until 2015. Prior to that, he was President and Chief Operating Officer of General Cable from 1999 to 2001 and Executive Vice President and Chief Operating Officer from 1997 to 1999. Mr. Kenny previously served in executive level positions at Penn Central Corporation, where he was responsible for corporate business strategy, and in diplomatic service as a Foreign Service Officer with the U.S. Department of State. Mr. Kenny, who has been our Chairman of the Board since November 2018, brings to the Board significant experience in the areas of board leadership, corporate governance, manufacturing operations, international markets, finance and human resources. He also draws upon his board governance and leadership experience previously chairing our Nominating and Governance and Human Resources and Compensation Committees and chairing Ingredion’s board of directors and its Corporate Governance and Nominating Committee. Both in his current role as Chairman of the Board and his prior role as independent Lead Director, Mr. Kenny has promoted strong independent Board leadership and a robust, deliberative decision-making process among independent directors. Mr. Kenny also brings to the Board valuable perspectives and insights from his service on AK Steel’s board of directors.

Michael Kaufmann

Mr. Michael C. Kaufmann is Chief Executive Officer, Director of the Company. He joined Cardinal Health in 1990 and has served as chief financial officer of the company since 2014. During that time, he has overseen all of the financial activities for the company including external reporting, investor relations, tax strategy/planning, and capital deployment as well as Global Sourcing for both the Pharmaceutical and Medical segments. During his 27 years at Cardinal Health, Kaufmann has served in a wide range of leadership positions across operations, sales and finance roles touching all areas of Cardinal Health. Kaufmann was instrumental in orchestrating key activities such as the joint venture with CVS Health that formed Red Oak Sourcing and the creation of Fuse, the Cardinal Health technology innovation center. Kaufmann serves as executive sponsor of the Cardinal Health Women's Initiative Network, an employee resource group with the goal to foster a culture of partnerships that makes Cardinal Health a suitable place for women to work and grow their careers. His support of women leaders in healthcare led to the Healthcare Businesswomen's Association naming Kaufmann as its 2012 "Honorable Mentor" and the Institute for Women's Leadership awarding him the 2014 "Guys Who Get it Award." He currently serves as a member of the board of directors for MSC Industrial Supply and on the executive board of Red Oak Sourcing. Kaufmann is a past member of the executive committee of both the Healthcare Distribution Management Association and the National Association of Chain Drug Stores. He also serves as a trustee atOhio Northern Universityand is an active member of the community. Prior to Cardinal Health, Kaufmann had a successful career in audit and consulting with Arthur Andersen, one of the nation's largest public accounting firms. He earned a bachelor's degree in business administration fromOhio Northern UniversityinAda, Ohio.

Jason Hollar

Mr. Jason M. Hollar has been appointed as Chief Financial Officer of the Company effective 5/12/2020. Mr. Hollar has been Executive Vice President and CFO of Tenneco Inc. ("Tenneco"), a company that designs, manufactures, markets and sells products and services for light vehicle, commercial truck, off-highway, industrial and after-market customers, since July 2018. He joined Tenneco as Senior Vice President Finance and served in that role from June 2017 to June 2018. Prior to joining Tenneco, Mr. Hollar was CFO of Sears Holdings Corporation ("Sears"), an integrated retailer, from October 2016 to April 2017 and prior to that served as Senior Vice President, Finance of Sears since October 2014.

Victor Crawford

Mr. Victor L. Crawford serves as Chief Executive Officer - Pharmaceutical segment of the Company. From September 2012 until November 2018, Mr. Crawford served as the Chief Operating Officer, Healthcare, Education, Business Dining for Aramark Corporation.

Stephen Mason

Mr. Stephen Mason is appointed as Chief Executive Officer-Medical Segment of the Company, effective August 16, 2019. Mr. Mason is a highly accomplished 20-year veteran of Cardinal Health and has successfully led several businesses within both Cardinal Health’s Medical and Pharmaceutical segments. Since 2016, Mr. Mason has overseen Cardinal Health at-Home Solutions, a component of the Medical segment that has delivered strong and consistent growth. Prior to that, he led Cardinal Health’s Kinray pharmaceutical distribution business. Mr. Mason also has deep experience leading sales, sales operations, and sourcing teams within the company’s Pharmaceutical Distribution business, including the Consumer Health, Sales Administration, Retail Independent Sales and Retail National Accounts teams.

Ola Snow

Mr. Ola M. Snow serves as Chief Human Resources Officer of the Company. Ms. Snow has served as Chief Human Resources Officer since October 2018. From January 2016 through September 2018, Ms. Snow served as Senior Vice President, Human Resources, Total Rewards, Talent Acquisition and Corporate Business Partner. From November 2012 to January 2016, she served as the Senior Vice President of Human Resources for the Medical segment.

Brian Rice

Mr. Brian S. Rice serves as Executive Vice President, Chief Information Officer and Customer Support Services of the Company. From 2009 until the beginning of 2019, Mr. Rice served as Senior Vice President, Chief Information Officer & Global and Business Services for Kellogg Company.

Jessica Mayer

Ms. Jessica L. Mayer serves as Chief Legal and Compliance Officer of the Company. Ms. Mayer has served as Chief Legal and Compliance Officer since March 2019. Ms. Mayer served as Executive Vice President, Deputy General Counsel and Secretary from September 2017 through March 2019. From December 2015 through September 2017, Ms. Mayer served as Senior Vice President, Deputy General Counsel, and from June 2008 to December 2015, she was Vice President, Managing Counsel

Carrie Cox

Ms. Carrie S. Cox serves as Independent Director of Cardinal Health Inc. Ms. Cox served as Chairman and Chief Executive Officer of Humacyte, Inc., a privately held, development stage company focused on regenerative medicine, from 2010 to 2018 and as its Executive Chairman from 2018 to 2019. She was Executive Vice President and President of Global Pharmaceuticals at Schering-Plough Corporation, a multinational branded pharmaceutical manufacturer, from 2003 until its merger with Merck & Co. in 2009. She was Executive Vice President and President of the Global Prescription Business of Pharmacia Corporation, a pharmaceutical and biotechnology company, from 1997 to 2003. Through her roles as an executive of Schering-Plough, President of Pharmacia’s Global Prescription business and Chief Executive Officer of Humacyte and as a licensed pharmacist, Ms. Cox brings to the Board substantial expertise in healthcare, particularly the branded pharmaceutical and international aspects. She draws on this experience in discussions relating to Pharmaceutical segment strategy, healthcare compliance and the opioid epidemic, including in meetings of the Board’s Ad Hoc Committee. Ms. Cox worked in the global branded pharmaceutical industry for over 30 years, giving her relevant experience with large, multinational healthcare companies in the areas of regulatory compliance, global markets and manufacturing operations. She also brings to the Board and to her role chairing our Human Resources and Compensation Committee, valuable perspectives and insights from her service on the boards of directors of Celgene, electroCore and Texas Instruments and prior service on the Array BioPharma board. She previously served as Chairman of the Board at Array BioPharma and Lead Director at Texas Instruments and currently sits on Texas Instruments’ Compensation Committee and Celgene’s Compensation and Development Committee

Calvin Darden

Mr. Calvin Darden serves as Independent Director of Cardinal Health, Inc. Mr. Darden was Senior Vice President of U.S. Operations of United Parcel Service, Inc. (“UPS”), an express carrier and package delivery company, from 2000 until 2005. During his 33-year career with UPS, he served in a number of senior leadership positions, including developing the corporate quality strategy for UPS and leading the business and logistics operations for its Pacific Region, the largest region of UPS at that time. A former executive of UPS, Mr. Darden has expertise in supply chain networks and logistics that contributes to the Board’s understanding of these important aspects of our business. He has over 30 years of relevant experience in the areas of operations, distribution and supply chain, efficiency and quality control, human resources and labor relations. He also brings to the Board valuable perspectives and insights from his service on the boards of directors of Aramark and Target, including their respective Compensation Committees, as well as his prior service on the board of directors of Coca-Cola Enterprises, including its Human Resources and Compensation Committee.

Bruce Downey

Mr. Bruce L. Downey serves as Independent Director of Cardinal Health Inc. Mr. Downey was Chairman and Chief Executive Officer of Barr Pharmaceuticals, Inc., a global generic pharmaceutical manufacturer, from 1994 until 2008 when the company was acquired by Teva Pharmaceutical Industries Ltd. Mr. Downey has served on a part-time basis as a Partner of NewSpring Health Capital II, L.P., a venture capital firm, since 2009. Before his career at Barr Pharmaceuticals, Mr. Downey was a practicing attorney for 20 years, having worked in both private practice and with the U.S. Department of Justice. Having spent 14 years as Chairman and Chief Executive Officer of Barr Pharmaceuticals, Mr. Downey brings to the Board substantial global experience in the areas of healthcare, regulatory compliance, manufacturing operations, finance, human resources and corporate governance. He offers valuable experience in the pharmaceutical and international aspects of our businesses, and he draws on his extensive legal and healthcare experience in chairing the Ad Hoc Committee and leading Board discussions related to opioid litigation and the opioid epidemic. Mr. Downey also brings to the Board valuable perspectives and insights from his service on the boards of directors of Melinta Therapeutics and Momenta Pharmaceuticals (including as its independent chair)

Sheri Edison

Ms. Sheri H. Edison serves as Independent Director of the Company. Ms. Edison currently serves as Executive Vice President and General Counsel for Amcor plc, a global leader in packaging for products spanning the food, beverage, pharmaceutical, medical, home and personal care sectors, with approximately 50,000 employees across more than 40 countries. She previously held the role of Senior Vice President, Chief Legal Officer and Secretary for Bemis Company, Inc. until it was acquired by Amcor, as well as Senior Vice President, Chief Administrative Officer of the medical device company Hill-Rom Holdings, Inc. Prior to these positions, Ms. Edison also served in multiple senior legal roles at other leading companies and as an attorney in private practice.

David Evans

Mr. David C. Evans has been appointed as Independent Director of the Company effective 7/1/2020. Mr. Evans has previously served as Executive Vice President and Chief Financial Officer of Battelle Memorial Institute, a private research and development organization, from 2013 to 2018. Prior to that, he was Executive Vice President and Chief Financial Officer of The Scotts Miracle-Gro Company, the leading manufacturer and marketer of branded consumer lawn and garden products in North America, from 2006 to 2013. Most recently, Mr. Evans was interim Chief Financial Officer of the Company from September 1, 2019 through May 25, 2020 after a transition role beginning July 29, 2019.

Patricia Hemingway Hall

Ms. Patricia A. Hemingway Hall serves as Independent Director of Cardinal Health, Inc. Ms. Hemingway Hall served as President and Chief Executive Officer of Health Care Service Corporation, a mutual health insurer (“HCSC”), from 2008 until 2016. Previously, she held several executive leadership positions at HCSC, including President and Chief Operating Officer from 2007 to 2008 and Executive Vice President of Internal Operations from 2006 to 2007. As retired President and Chief Executive Officer of HCSC, the largest customer-owned health insurer in the United States operating through several state Blue Cross and Blue Shield Plans, Ms. Hemingway Hall brings to the Board valuable experience regarding evolving healthcare payment models and the regulatory environment in the rapidly changing healthcare industry. She has worked in the healthcare industry for over 30 years, first as a registered nurse and later in health insurance, and has relevant experience in the areas of healthcare reform, regulatory compliance, government relations, finance, information technology and human resources. Ms. Hemingway Hall also brings to the Board and to her roles chairing our Nominating and Governance Committee and being a member of our Human Resources and Compensation Committee, valuable perspectives and insights from her service on the boards of directors of Celgene, Halliburton and ManpowerGroup. She chairs ManpowerGroup’s Nominating and Governance Committee and sits on its Audit Committee, sits on Celgene’s Audit Committee and sits on Halliburton’s Compensation and Nominating and Corporate Governance Committees.

Akhil Johri

Mr. Akhil Johri is Independent Director of the company. Mr. Johri has served as Executive Vice President and Chief Financial Officer of United Technologies Corporation (“UTC”), a provider of high technology products and services to the building systems and aerospace industries, since 2015. From 2013 to 2014, he served as Chief Financial Officer and Chief Accounting Officer of Pall Corporation, a global supplier of filtration, separations and purifications products, and from 2011 to 2013, he was Vice President of Finance and Chief Financial Officer of UTC Propulsion & Aerospace Systems, which included Pratt & Whitney and UTC Aerospace Systems. Mr. Johri’s prior roles with UTC include leading investor relations, as well as holding senior financial roles with global business units, including 12 years in the Asia Pacific Region. Having spent more than 25 years in financial leadership positions with UTC and Pall Corporation, Mr. Johri brings to the Board substantial experience in the areas of global finance and accounting, investor relations, mergers and acquisitions, information technology and international markets. Drawing upon his financial expertise, he provides valuable insights in the areas of financial reporting, accounting, internal controls and capital markets, as well as international tax and finance. Through his experience in senior leadership roles with UTC’s businesses, he provides a deep understanding of the financial aspects of, and capital deployment for, a publicly traded multinational company.

Nancy Killefer

Ms. Nancy Killefer serves as Independent Director of the Company. Ms. Killefer served as Senior Partner of McKinsey & Company, Inc., a global management consulting firm, from 1992 until 2013. She joined McKinsey in 1979 and held a number of key leadership roles, including serving as a member of the firm’s governing board. Ms. Killefer founded McKinsey’s Public Sector Practice in 2007 and served as its managing partner until her retirement. She also served as Assistant Secretary for Management, Chief Financial Officer and Chief Operating Officer for the U.S. Department of Treasury from 1997 to 2000. Having served in key leadership positions in both the public and private sectors and provided strategic counsel to healthcare and consumer-based companies during her 30 years with McKinsey, Ms. Killefer brings to the Board substantial experience in the areas of strategic planning, including healthcare strategy, and marketing and brand-building. Her extensive experience as managing partner of McKinsey’s Public Sector Practice and as a chief financial officer of a government agency provides valuable insights in the areas of government relations, public policy and finance. Ms. Killefer also brings to the Board valuable perspectives and insights from her service on the board of directors of Avon Products, including its Compensation and Management Development Committee, and Taubman Centers and her prior service on the boards of directors of CSRA, Inc. (including as its independent chair), Computer Sciences Corporation and The Advisory Board.

John Losh

Mr. John Michael Losh serves as Director of Cardinal Health, Inc. He was Chief Financial Officer of Cardinal Health (on an interim basis) from July 2004 to May 2005. He was Chairman of Metaldyne Corporation, an automotive parts manufacturer, from October 2000 to April 2002 and Chief Financial Officer of General Motors Corporation, an automobile manufacturer, from 1994 to August 2000. Mr. Losh is a Member of the Board of AMB Property Corporation, an industrial real estate owner and operator, Aon Corporation, a provider of risk management services, insurance and reinsurance brokerage, and human capital consulting (“Aon”), H.B. Fuller Company, a specialty chemicals and industrial adhesives manufacturer, Masco Corp., a manufacturer of home improvement and building products and TRW Automotive Holdings Corp., a supplier of automotive systems, modules and components.

Dean Scarborough

Mr. Dean Scarborough is Independent Director of the Company. Mr. Scarborough served as Chairman and Chief Executive Officer of Avery Dennison Corporation, a packaging and labeling solutions company, from 2014 to 2016. Prior to that, he served as Avery Dennison’s Chairman, President and Chief Executive Officer from 2010 to 2014 and as its President and Chief Executive Officer from 2005 to 2010. After stepping down as Chief Executive Officer, Mr. Scarborough remained Chairman of the Board through April 2019. Having joined Avery Dennison in 1983, Mr. Scarborough served in a series of leadership roles both in the United States and abroad until he was appointed Chief Operating Officer in 2000 and later Chief Executive Officer. Having served as Avery Dennison’s Chief Executive Officer for 11 years, Mr. Scarborough brings to the Board substantial experience in manufacturing and distribution operations. As a former public company chief executive officer, he has relevant experience in finance, human resources and corporate governance. He also brings a global business and manufacturing perspective, having led Avery Dennison’s Label and Packaging Materials Europe business while he was based in the Netherlands. Mr. Scarborough also brings to the Board valuable perspectives and insights from his service on the board of directors of Graphic Packaging Holding Company, including its Audit Committee, and prior service on Mattel, Inc.’s board of directors.

John Weiland

Mr. John H. Weiland is Independent Director of the Company. Mr. Weiland served as President and Chief Operating Officer of medical device company C. R. Bard, Inc. from 2003 until 2017, when Bard was acquired by Becton, Dickinson and Company. He also served on Bard’s board of directors from 2005 to 2017, becoming Vice Chairman of the Board in 2016. Mr. Weiland joined Bard in 1996 and held the position of Group President, with global responsibility for several Bard divisions and its worldwide manufacturing operations prior to becoming President and Chief Operating Officer. Prior to Bard, he held senior management positions at Dentsply International, American Hospital Supply, Baxter Healthcare and Pharmacia AB. Mr. Weiland brings over 40 years of healthcare industry experience to the Board, including executive leadership at a medical device company and significant international business experience. He has relevant experience in regulatory compliance, global markets and manufacturing operations. Mr. Weiland also brings to the Board valuable perspectives and insights from his service on the board of directors of Celgene Corporation, including its Audit Committee, and prior service on West Pharmaceutical Services’ board of directors, including chairing its Compensation and Finance Committees.